{"id":"https://openalex.org/W2082828007","doi":"https://doi.org/10.2147/dddt.s68579","title":"Decision-making in product portfolios of pharmaceutical research and development \u2013 managing streams of innovation in highly regulated markets","display_name":"Decision-making in product portfolios of pharmaceutical research and development \u2013 managing streams of innovation in highly regulated markets","publication_year":2014,"publication_date":"2014-10-01","ids":{"openalex":"https://openalex.org/W2082828007","doi":"https://doi.org/10.2147/dddt.s68579","mag":"2082828007","pmid":"https://pubmed.ncbi.nlm.nih.gov/25364229","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4211845"},"language":"en","primary_location":{"id":"doi:10.2147/dddt.s68579","doi":"https://doi.org/10.2147/dddt.s68579","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s68579","pdf_url":"https://www.dovepress.com/getfile.php?fileID=22121","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=22121","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110161832","display_name":"Antii Jekunen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Antii Jekunen","raw_affiliation_strings":["Vaasa Oncology Clinic, Vaasa, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaasa Oncology Clinic, Vaasa, Finland","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5110161832"],"corresponding_institution_ids":[],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":0.6309,"has_fulltext":true,"cited_by_count":56,"citation_normalized_percentile":{"value":0.59002169,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"8","issue":null,"first_page":"2009","last_page":"2009"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.975600004196167,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.975600004196167,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11976","display_name":"Capital Investment and Risk Analysis","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/2003","display_name":"Finance"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T14306","display_name":"Technology Assessment and Management","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/1405","display_name":"Management of Technology and Innovation"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-development-decision-making","display_name":"drug development decision-making","score":0.7039999961853027},{"id":"https://openalex.org/keywords/anticancer-drug-development","display_name":"anticancer drug development","score":0.8130000233650208},{"id":"https://openalex.org/keywords/patent-evaluation","display_name":"patent evaluation","score":0.7879999876022339},{"id":"https://openalex.org/keywords/regulatory-approval","display_name":"regulatory approval","score":0.34700000286102295},{"id":"https://openalex.org/keywords/r-d-pipeline","display_name":"R&D pipeline","score":0.6940000057220459},{"id":"https://openalex.org/keywords/drug-development-strategy","display_name":"drug development strategy","score":0.39800000190734863}],"concepts":[{"id":"https://openalex.org/C2780821815","wikidata":"https://www.wikidata.org/wiki/Q5340806","display_name":"Portfolio","level":2,"score":0.7635248899459839},{"id":"https://openalex.org/C19351080","wikidata":"https://www.wikidata.org/wiki/Q1395034","display_name":"New product development","level":2,"score":0.7109321355819702},{"id":"https://openalex.org/C2779635493","wikidata":"https://www.wikidata.org/wiki/Q11279702","display_name":"Patent portfolio","level":3,"score":0.6201409697532654},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.5917829275131226},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.4909808933734894},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.48802104592323303},{"id":"https://openalex.org/C90673727","wikidata":"https://www.wikidata.org/wiki/Q901718","display_name":"Product (mathematics)","level":2,"score":0.43227776885032654},{"id":"https://openalex.org/C9725762","wikidata":"https://www.wikidata.org/wiki/Q1072885","display_name":"Modern portfolio theory","level":3,"score":0.42359423637390137},{"id":"https://openalex.org/C74510933","wikidata":"https://www.wikidata.org/wiki/Q1936145","display_name":"Project portfolio management","level":3,"score":0.42317190766334534},{"id":"https://openalex.org/C73938075","wikidata":"https://www.wikidata.org/wiki/Q2858767","display_name":"Application portfolio management","level":4,"score":0.41754817962646484},{"id":"https://openalex.org/C195094911","wikidata":"https://www.wikidata.org/wiki/Q14167904","display_name":"Process management","level":1,"score":0.3684813976287842},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.32661157846450806},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.29947322607040405},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.28771114349365234},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.21316754817962646},{"id":"https://openalex.org/C34974158","wikidata":"https://www.wikidata.org/wiki/Q131257","display_name":"Intellectual property","level":2,"score":0.2024221122264862},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.15056690573692322},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.14731892943382263},{"id":"https://openalex.org/C15952604","wikidata":"https://www.wikidata.org/wiki/Q179012","display_name":"Project management","level":2,"score":0.13412365317344666},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.134051114320755},{"id":"https://openalex.org/C187736073","wikidata":"https://www.wikidata.org/wiki/Q2920921","display_name":"Management","level":1,"score":0.12931334972381592},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003657","descriptor_name":"Decision Making","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":"Q000458","qualifier_name":"organization & administration","is_major_topic":false},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D035843","descriptor_name":"Biomedical Research","qualifier_ui":"Q000458","qualifier_name":"organization & administration","is_major_topic":true},{"descriptor_ui":"D040541","descriptor_name":"Marketing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.2147/dddt.s68579","doi":"https://doi.org/10.2147/dddt.s68579","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s68579","pdf_url":"https://www.dovepress.com/getfile.php?fileID=22121","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4211845","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4211845","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Des Devel Ther","raw_type":"Text"},{"id":"pmid:25364229","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25364229","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug design, development and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:dovepress.com/18857","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/decision-making-in-product-portfolios-of-pharmaceutical-research-and-d-peer-reviewed-article-DDDT","pdf_url":"https://www.dovepress.com/decision-making-in-product-portfolios-of-pharmaceutical-research-and-d-peer-reviewed-article-DDDT","source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Review"},{"id":"pmh:oai:doaj.org/article:51e257f65a4d4509a16496b2c233acaa","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/51e257f65a4d4509a16496b2c233acaa","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Drug Design, Development and Therapy, Vol 2014, Iss default, Pp 2009-2016 (2014)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.2147/dddt.s68579","doi":"https://doi.org/10.2147/dddt.s68579","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s68579","pdf_url":"https://www.dovepress.com/getfile.php?fileID=22121","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320326518","display_name":"Tays","ror":"https://ror.org/02hvt5f17"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2082828007.pdf","grobid_xml":"https://content.openalex.org/works/W2082828007.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W120574610","https://openalex.org/W210903667","https://openalex.org/W376065488","https://openalex.org/W642958107","https://openalex.org/W1496348803","https://openalex.org/W1498780613","https://openalex.org/W1589611655","https://openalex.org/W1593284199","https://openalex.org/W1606815949","https://openalex.org/W1985020560","https://openalex.org/W1997018323","https://openalex.org/W2011648818","https://openalex.org/W2044418414","https://openalex.org/W2052380543","https://openalex.org/W2059170763","https://openalex.org/W2068425794","https://openalex.org/W2085703367","https://openalex.org/W2087274024","https://openalex.org/W2099485489","https://openalex.org/W2103157313","https://openalex.org/W2109101741","https://openalex.org/W2116897501","https://openalex.org/W2118511931","https://openalex.org/W2122567999","https://openalex.org/W2127913319","https://openalex.org/W2135582661","https://openalex.org/W2140999134","https://openalex.org/W2150658633","https://openalex.org/W2154950075","https://openalex.org/W2163641917","https://openalex.org/W2282527030","https://openalex.org/W2768244897","https://openalex.org/W3024922123","https://openalex.org/W3121571701"],"related_works":["https://openalex.org/W7100196773","https://openalex.org/W2161723120","https://openalex.org/W2950596344","https://openalex.org/W204521830","https://openalex.org/W2132177992","https://openalex.org/W1561928416","https://openalex.org/W3120282249","https://openalex.org/W2800499373","https://openalex.org/W1921879067","https://openalex.org/W650303382"],"abstract_inverted_index":{"Decision-making":[0],"is":[1,26],"a":[2,13,38,60],"core":[3],"function":[4],"of":[5,51,57,83,109,115,156],"any":[6],"drug":[7,30,61,117,133,169],"development":[8,31,62,82,120,166],"firm.":[9],"Developing":[10],"drugs":[11,58,85,157],"demands":[12],"firm":[14,63],"to":[15,35],"be":[16,68,140],"highly":[17],"innovative,":[18],"while":[19],"at":[20,96],"the":[21,24,33,49,76,81,89,97,100,107,113,116,173,177],"same":[22],"time":[23],"activity":[25],"strictly":[27],"regulated.":[28],"Successful":[29],"offers":[32],"right":[34],"apply":[36],"for":[37,59,91,104],"long-term":[39],"patent":[40],"that":[41],"confers":[42],"exclusive":[43],"marketing":[44],"rights.":[45],"This":[46],"article":[47],"addresses":[48],"issue":[50],"what":[52,145],"constitutes":[53],"an":[54],"adequate":[55],"portfolio":[56,105,134,170],"and":[64,78,111,130,165,168],"how":[65],"it":[66],"might":[67],"managed":[69],"successfully.":[70],"The":[71],"paper":[72],"investigates":[73],"decision-making":[74,95,137],"in":[75,80,132,158,176],"industry":[77],"specifically":[79],"oncology":[84],"from":[86],"various":[87],"perspectives:":[88],"need":[90],"decisions,":[92],"their":[93],"timing,":[94],"project":[98],"level,":[99],"optimal":[101],"portfolio,":[102],"tools":[103],"analysis,":[106],"evaluation":[108],"patents,":[110],"finally":[112],"importance":[114],"portfolio.":[118],"Drug":[119],"decisions":[121,131,150],"as":[122],"important":[123],"organizational":[124],"elements":[125,175],"should":[126,139],"get":[127],"more":[128,142],"emphasis,":[129],"using":[135],"modern":[136],"methods":[138],"used":[141],"widely":[143],"than":[144],"currently":[146],"happens.":[147],"Structured,":[148],"informed":[149],"would":[151],"help":[152],"avoiding":[153],"late":[154],"terminations":[155],"Phase":[159],"III":[160],"development.":[161],"An":[162],"improved":[163],"research":[164],"pipeline":[167],"management":[171],"are":[172],"major":[174],"general":[178],"strategy":[179],"targeting":[180],"success.":[181]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}